vaccines

  1. S

    VBI Vaccines Inc. - Case Study | Case Studies | Business Case Study

    Case studies are stories. They present realistic, complex, and contextually rich situations and often involve a dilemma, conflict, or problem that one or more of the characters in the case must negotiate. They “bridge the gap between theory and practice and between the academy and the...
  2. K

    Project report on VBI Vaccines Inc.

    Hello everyone, I need information to prepare Research report on VBI Vaccines Inc. Can someone please help me with it?
  3. J

    Company Profile of VBI Vaccines Inc.

    Can Someone Help me with Company Profile of VBI Vaccines Inc.? Any Links to Company Profile sites for VBI Vaccines Inc. on public companies trading on the NYSE, NASDAQ, AMEX, and OTC exchanges will be greatly appreciated.
  4. P

    Hepatitis Treatments and Vaccines: World Market 2012-2022

    Description Bharat Book introduces a report " Hepatitis Treatments and Vaccines " Our study is for everybody needing industry and market analyses for hepatitis-treating drugs and vaccines. qwertyuiopasdfghjklzxcvbnmqwer tyuiopasdfghjklzxcvbnmqwertyuio pasdfghjklzxcvbnmqwertyuiopasd...
  5. P

    Global Veterinary Vaccines - Global Value Market Estimations & Predictions

    Description Bharatbook from its exhaustive collection has come out with a report " Global Veterinary Vaccines - Global Value Market Estimations & Predictions " which gives an overview, Demand, Supply Trends and industry analysis reports. Global Veterinary Vaccines - Global Value Market...
  6. P

    Needle-Free Delivery: Technology and Market 2012-2022

    Description Bharatbook from its exhaustive collection has come out with a report " Needle-Free Delivery: Technology and Market 2012-2022 " which gives an overview, Demand, Supply Trends and industry analysis reports. Needle-Free Delivery: Technology and Market 2012-2022 Bharatbook from its...
  7. D

    Making Markets for Vaccines

    An advance market commitment would ensure that funds are available to buy the vaccines when they are developed. It could be structured to guarantee that after the pre-determined number of doses has been purchased at a price that rewards the innovating company, the price would fall to a...
  8. M

    VaxInnate to Discuss Seasonal and Pandemic Flu Vaccines During BIO 2008 This Week

    VaxInnate to Discuss Seasonal and Pandemic Flu Vaccines During BIO 2008 This Week ... for the Next Pandemic," 8:15-9:45 am in Room 29A - including Robert Becker, PhD, MBA, VaxInnate's Vice President of Business Development On Thursday, June 19th -- "Vaccine Renaissance," 8:30-10:00 ... More...
  9. M

    VaxInnate to Discuss Seasonal and Pandemic Flu Vaccines During BIO 2008 This Week

    VaxInnate to Discuss Seasonal and Pandemic Flu Vaccines During BIO 2008 This Week ... for the Next Pandemic," 8:15-9:45 am in Room 29A - including Robert Becker, PhD, MBA, VaxInnate's Vice President of Business Development -- "Vaccine Renaissance," 8:30-10:00 am, Room 29A - ... More...
  10. M

    VaxInnate to discuss seasonal and pandemic flu vaccines during BIO 2008 this week

    VaxInnate to discuss seasonal and pandemic flu vaccines during BIO 2008 this week ... for the Next Pandemic," 8:15-9:45 am in Room 29A including Robert Becker, PhD, MBA, VaxInnate's Vice President of Business Development "Vaccine Renaissance," 8:30-10:00 am, Room 29A including ... More...
Back
Top